Combination of Linagliptin and Metformin for the Treatment of Patients with Type 2 Diabetes

Type 2 diabetes mellitus (T2DM) is a progressive condition requiring long-term treatment. Most patients with T2DM are unable to maintain normoglycemia using metformin alone; thus, combination therapy is a pivotal part of disease management. Addition of the dipeptidyl peptidase-4 inhibitor linaglipti...

Descripción completa

Detalles Bibliográficos
Autor principal: Haak, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284079/
https://www.ncbi.nlm.nih.gov/pubmed/25628514
http://dx.doi.org/10.4137/CMED.S10360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284079/
https://www.ncbi.nlm.nih.gov/pubmed/25628514
http://dx.doi.org/10.4137/CMED.S10360

Ejemplares similares